IL17RA and Bartsocas-Papas syndrome 1: Our findings suggest that IL17RA upregulation may be responsible for the long-term chronic inflammation seen in IC/BPS, which encourages us to look further into the role of IL17RA in the pathogenesis of IC/BPS and the possibility of IL17RA targeting drugs in the treatment of IC/BPS.